Ctxr marketwatch
Web1 day ago · Market Cap $16.72M Shares Outstanding 17.24M Public Float 16.44M Beta 0.91 Rev. per Employee $113.10K P/E Ratio N/A EPS -$1.1270 Yield N/A Dividend N/A Ex-Dividend Date N/A Short Interest 663.77K... WebCTXR Citius Pharmaceuticals Inc. Profile MarketWatch Citius Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch. Citius …
Ctxr marketwatch
Did you know?
WebCitius Pharmaceuticals Inc. on Wednesday said it filed for U.S. Food and Drug Administration approval of its lead product candidate denileukin diftitox, also known as I/Ontak, for the treatment of... WebCTXR - Citius Pharmaceuticals Inc. Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.
WebApr 6, 2024 · CTXR Articles Average Week Source Sentiment All Sentiments This page (NASDAQ:CTXR) was last updated on 4/1/2024 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring WebJul 1, 2024 · Shares of Citius Pharmaceuticals ( CTXR -0.99%), a clinical-stage biopharmaceutical company, are getting beaten down today after the company released disappointing news regarding its lead...
Web20 hours ago · Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1% 06/30/20-7:54AM EST Zacks. Other News for CTXR Maxim Group Reaffirms Their Buy Rating on Citius Pharmaceuticals (CTXR) 04/04/23-11:25AM EST ... WebUEC Complete Uranium Energy Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
WebCTXR 15Min Scalper's edition test Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives …
WebSep 9, 2024 · CTXR - Citius Pharmaceuticals Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. 1 day 2 days 5 days 10 … hagnard bluetoothWebApr 4, 2024 · Earnings Summary. For their last quarter, Citius Pharmaceuticals (CTXR) reported earnings of -$0.04 per share. This reflects a breakeven earnings surprise. Look out for CTXR's next earnings ... branch line trains coachesWebCitius Pharmaceuticals Inc. Quarterly balance sheet by MarketWatch. View all CTXR assets, cash, debt, liabilities, shareholder equity and investments. branch list vrlbranch line tree services wetherbyWebApr 10, 2024 · TSOI Complete Therapeutic Solutions International Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. hagnau im hof 7WebThe 3 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 4.00. The … branch lines to sudburyWebCTX Virtual Technologies, Inc. engages in the development and market of multi-touch technology platform, virtual keyboard and applications. Its products include VK200 KEYFOB, MISEETX, VK300 iPhone ... branch line with some storage capacity